The CBD Guys disrupt Australian Medicinal Cannabis Market with launch of their first brand, Humacology — Affordable medicinal cannabis for every Australian patient has arrived.
NOOSA HEADS, Queensland, Australia – Go-to market medicinal cannabis specialists The CBD Guys have launched their first brand – Humacology – to Australian patients, with four CBD-based oils available on the Special Access or Authorised Prescriber Schemes.
Noted medicinal cannabis doctor Dr. Crosby Rechtin, The CBD Guys’ Co-founder and Chief Medical Officer, says Humacology will present a retail price of 14%-28% less than current price leaders and 32%-57% less than the industry averages for similar medicines.
“For too long, Australian patients have been paying too much for medicinal cannabis,” Dr. Rechtin said. “It’s by far the biggest frustration my patients have in getting the medicine they desperately need.”
Dr. Rechtin says many patients end up dosing themselves with less than what has been prescribed to make their costly prescription last longer, something that can often impact the medicine’s effectiveness. “If they can’t afford to take the correct dose of CBD – or any medicine for that matter – they’re not giving the medicine the chance to do what it’s been designed to do.”
The THC and CBD in Humacology oils are extracted at a state-of-the-art U.S.A-based facility co-owned by James Dale, CEO of The CBD Guys and co-founder of Humacology.
“The U.S. market is probably 10 years ahead of the Australian market – in extraction methods, lab testing and formulating techniques. We are the first to bring all these advancements to Australian patients with what we believe are the most pure and effective medicinal cannabis products in the world,” New York City-based Dale said.
It is this direct-to-consumer model that allows Humacology to enter the market at a disruptive price point. Sam Saunders, Chief Creation Officer and third co-founder says, “We are a wellness company that believes in the incredible power of medicinal cannabis, and believe patients should be able to afford it. We are so proud to be Australia’s first and only affordable medicinal cannabis brand in a category that is filled with patients unhappy with the cost of their treatments. The market was ripe for an affordable alternative, and that alternative is Humacology.”
Saunders adds, “Our number one focus is to make Australian patients better – better health-wise, mentally and physically, and thus better as people in their everyday lives, relationships and communities.”
Humacology is launching with four CBD-based oils: a 0:100 CBD isolate, a 1:100, a 5:100 and a 27:27 balance product, all containing the plant’s natural terpenes and a majority delta 8 THC.
“I formulated our four Humacology oils specifically for Australian patients’ needs,” Dr. Rechtin said. “I added delta 8 THC to give the smoothest possible and broadly beneficial effect, which is especially important for patients who might be hesitant to take medicinal cannabis because of side-effects like paranoia and increased appetite that some experience from delta 9 THC.”
Part of The CBD Guys’ strategy to ensure success in the Australian market was to enlist Health House International Limited (ASX:HHI) as exclusive distributors, with whom they signed a two-year deal earlier this year.
Health House Chief Operating Officer – Australasia, Paul Mavor said “The CBD Guys have a great team. They have a mix of medical headed by Dr. Crosby Rechtin, and marketing. Their Missouri, U.S.A. extraction facility will be producing a pipeline of unique and affordable products for the Australian market.”
James Dale added,“Health House are the perfect partner for us, and are already consulting with their European offices to expand Humacology to new markets. We are thrilled to partner with Paul and his dynamic team.”
The CBD Guys are based in Noosa Heads, Queensland, New York City, and Missouri, USA.
THE CBD GUYS CONTACTS (PRESS FEEL FREE TO CONTACT US DIRECTLY)
HEALTH HOUSE CONTACTS
COO – Australasia
UK & Europe:
COO – U.K. & Europe
Instagram + Facebook: @humacology | humacology.com.au
The CBD Guys disrupt Australian Medicinal Cannabis Market
Cannin Investment Group: Your Hemp Stocks Experts
Cannin.com is your trusted resource for top hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2021.
Use Cannin as your resource for:
Is it too late to invest in hemp stocks? No! This is the perfect time to invest.
Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.
Are you looking to buy stock in hemp companies or stock in cannabis companies in 2021? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks? We can help.
Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best hemp stocks – we’ll show you how at cannin.com.